MARKET PULSE-Quiksilver, Doral Financial, Krispy Kreme, casino operators
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks edged lower in early trading on Tuesday, receding from record levels as traders found few reasons to buy following a string of gains. The Dow Jones industrial average was down 0.22 percent at 16,706.09 and the S&P 500 was down 0.18 percent at 1,921.53.
** QUIKSILVER INC, $3.21, -44.56 pct
The apparel and accessories retailer reported a bigger quarterly loss, hurt by lower wholesale sales in North America and Europe.
** PROSENSA HOLDING NV, $10.82, +2 pct
The company said the U.S. Food and Drug Administration had outlined a regulatory path for the accelerated approval of its lead drug. The drug, drisapersen, is being developed to treat Duchenne muscular dystrophy - a muscle-wasting disorder that affects one in every 3,500 newborn boys - that has no available cure.
** CLOVIS ONCOLOGY INC, $40.0801, -16.06 pct Continued...